AstraZeneca agrees to decrease drug costs for Medicaid

-

By WILL WEISSERT, Related Press

WASHINGTON (AP) — AstraZeneca on Friday grew to become the second main pharmaceutical producer to announce it had agreed to decrease the price of prescribed drugs for Medicaid below a deal struck with the Trump administration that averted its threats of steep tariffs.

President Donald Trump made the announcement within the Oval Workplace with AstraZeneca CEO Pascal Soriot, who mentioned that in powerful negotiations to achieve a deal, Trump and his group of officers had “actually saved me up at evening.”

Below the settlement, AstraZeneca will cost most-favored-nation pricing to Medicaid, whereas guaranteeing such pricing on newly launched medicine, Trump mentioned. That entails matching the bottom worth provided in different developed nations.

“For a few years, People have paid the best costs on this planet for prescribed drugs, by far,” Trump mentioned, including that the brand new deal might reduce costs to “the bottom worth anyplace on this planet. That’s what we get.”

Share this article

Recent posts

Popular categories

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent comments